Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Phillip A. Low, Sid Gilman

Research output: Contribution to journalEditorial

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)4-5
Number of pages2
JournalAnnals of neurology
Volume72
Issue number1
DOIs
StatePublished - Jul 2012

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this